{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:49:45Z","timestamp":1787161785996,"version":"build-2736575974"},"reference-count":15,"publisher":"European Respiratory Society (ERS)","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2024,8,9]]},"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1183\/13993003.01178-2024","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T08:58:05Z","timestamp":1725526685000},"page":"2401178","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["The younger, the better: lessons learned from real-world studies on CFTR modulators in young children"],"prefix":"10.1183","volume":"64","author":[{"given":"Philippe","family":"Reix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Chassagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"key":"2024102017361385000_64.3.2401178.1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201312-444LD"},{"key":"2024102017361385000_64.3.2401178.2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1164\/rccm.202404-0764ED","article-title":"Reversal of bronchiectasis in children: early intervention may stop the vicious circle!","volume":"210","author":"Burgel","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102017361385000_64.3.2401178.3","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1164\/rccm.202102-0509OC","article-title":"A phase 3 open-label study of elexacaftor\/tezacaftor\/ivacaftor in children 6 through 11 years of age with cystic fibrosis and at least one F508del allele","volume":"203","author":"Zemanick","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102017361385000_64.3.2401178.4","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202202-0392OC"},{"key":"2024102017361385000_64.3.2401178.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2013.09.005"},{"key":"2024102017361385000_64.3.2401178.6","doi-asserted-by":"crossref","first-page":"105954","DOI":"10.1016\/j.rmed.2020.105954","article-title":"Diagnosis and quantification of bronchiectasis using computed tomography or magnetic resonance imaging: a systematic review","volume":"170","author":"Meerburg","year":"2020","journal-title":"Respir Med"},{"key":"2024102017361385000_64.3.2401178.7","doi-asserted-by":"crossref","first-page":"e200022","DOI":"10.1148\/ryct.2020200022","article-title":"Quantification of cystic fibrosis lung disease with radiomics-based CT scores","volume":"2","author":"Chassagnon","year":"2020","journal-title":"Radiol Cardiothorac Imaging"},{"key":"2024102017361385000_64.3.2401178.8","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00004-2024"},{"key":"2024102017361385000_64.3.2401178.9","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1164\/rccm.202308-1317OC","article-title":"Improvement in lung clearance index and chest computed tomography scores with elexacaftor\/tezacaftor\/ivacaftor treatment in people with cystic fibrosis aged 12 years and older \u2013 the RECOVER trial","volume":"208","author":"McNally","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102017361385000_64.3.2401178.10","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202108-1986OC"},{"key":"2024102017361385000_64.3.2401178.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2011.02.045"},{"key":"2024102017361385000_64.3.2401178.12","unstructured":"Eurostat . Availability of CT and MRI Units in Hospitals. Date last updated: 2 July 2021. Date last accessed: 17 June 2024. https:\/\/ec.europa.eu\/eurostat\/web\/products-eurostat-news\/-\/ddn-20210702-2"},{"key":"2024102017361385000_64.3.2401178.13","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01794-2023"},{"key":"2024102017361385000_64.3.2401178.14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1164\/rccm.202402-0411OC","article-title":"Radiographic outcomes in paediatric bronchiectasis and factors associated with reversibility","volume":"210","author":"Mills","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102017361385000_64.3.2401178.15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jcf.2016.10.002","article-title":"Correlation of sweat chloride and percent predicted FEV1 in cystic fibrosis patients treated with ivacaftor","volume":"16","author":"Fidler","year":"2017","journal-title":"J Cyst Fibros"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01178-2024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T02:22:45Z","timestamp":1740363765000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01178-2024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":15,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,9,5]]},"published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1183\/13993003.01178-2024"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01178-2024","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9]]}}}